Neurology
Conference Coverage
Withdrawing risperidone spikes risk for psychotic relapse in hallucinating Alzheimer’s patients
Key clinical point: Risperidone-treated patients who reported severe hallucinations are likely to relapse if the drug is withdrawn. Major finding...
News
Start time for estrogen conveys no cognitive impact
Estradiol had no significant impact on cognitive function when taken within 6 years of menopause or more than 10 years after menopause.
Conference Coverage
Use simple algorithms to manage dementia
Commentary
How practice changes us
Will physicians be on the wrong side of medical history by providing patients with chronic pain access to medical marijuana?
News
Focused-ultrasound device approved to treat essential tremor
The FDA approved a device that treats essential tremor using transcranial focused ultrasound to destroy MRI-identified pathologic areas of the...
Conference Coverage
New data propel headache neuromodulation devices toward approval
Commentary
The nightmare of opioid addiction
Hospitalists want to relieve pain and suffering. There are few things as rewarding as doing so. But because we have not understood the long-term...
Commentary
The nightmare of opioid addiction
Hospitalists want to relieve pain and suffering. There are few things as rewarding as doing so. But because we have not understood the long-term...
News
Deutetrabenazine modestly reduces chorea of Huntington disease
A deuterated form of the vesicular monoamine transporter type 2 inhibitor tetrabenazine appears to modestly reduce chorea of Huntington disease...
News
Siponimod shows promise through 24 months in relapsing-remitting MS
Key clinical point: Siponimod was associated with sustained efficacy at 24 months among patients with relapsing-remitting multiple sclerosis....
Commentary
The hospitalist perspective on opioid prescribing
My colleagues and I wanted to explore hospitalists’ attitudes, beliefs, and practices associated with opioid prescribing during hospitalization...